Additional Work under Addendum. If the Supervisory Board determines that the changes are sufficiently minor that they can be implemented under this West Nile Virus Addendum, then the parties shall implement the process more particularly described in Section 3.3 above, and the Supervisory Board may approve a new WNV Development Program, consisting of a new modified Product Requirements Document, Software Requirements Specifications, Technical Plan, Resource Plan and Budget, for the purpose of developing such changes. Notwithstanding the foregoing, nothing herein shall obligate either party to conduct development work after the Completion Date with respect to the WNV Assay Product, without regard to whether the other party indicates a willingness to pay some portion or the entire costs of such development.
Appears in 2 contracts
Sources: Future Blood Screening Assay—west Nile Virus Addendum (Chiron Corp), Future Blood Screening Assay West Nile Virus Addendum (Gen Probe Inc)